Clinical Trial Update: Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for an ND4-targeted gene therapy for Leber Hereditary Optic Neuropathy (LHON); phases 1 and 2, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• ND4 gene therapy (ND4 gene therapy)

Snippet

Sponsor: Neurophth Therapeutics Inc | Conditions: Leber Hereditary Optic Neuropathy (LHON) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING